Insulin resistance in HIV protease inhibitor-associated diabetes. - Wikidata - wikimedia - TriplyDB

Insulin resistance in HIV protease inhibitor-associated diabetes.

Insulin resistance in HIV protease inhibitor-associated diabetes.

http://www.wikidata.org/entity/Q35237635

about

Drug-induced diabetes mellitus Optimal timing and duration of induction therapy for HIV-1 infection HIV-protease inhibitors induce expression of suppressor of cytokine signaling-1 in insulin-sensitive tissues and promote insulin resistance and type 2 diabetes mellitus Use Your Words Carefully: What Is a Chronic Disease?HIV-protease inhibitors suppress skeletal muscle fatty acid oxidation by reducing CD36 and CPT1 fatty acid transporters.Hyperglycemia associated with protease inhibitors in an urban HIV-infected minority patient population.Lipodystrophy syndrome in HIV infection: what is it, what causes it and how can it be managed?Disorders of glucose metabolism in patients infected with human immunodeficiency virus.Glucose disorders associated with HIV and its drug therapy.Effects of the HIV protease inhibitor ritonavir on GLUT4 knock-out mice.HIV protease inhibitors acutely impair glucose-stimulated insulin release.Post-exercise heart rate recovery in HIV-positive individuals on highly active antiretroviral therapy. Early indicator of cardiovascular disease?Hyperglycemia enhances kidney cell injury in HIVAN through down-regulation of vitamin D receptors Boosting dose ritonavir does not alter peripheral insulin sensitivity in healthy HIV-seronegative volunteers.Insulin resistance predicts endothelial dysfunction and cardiovascular risk in HIV-infected persons on long-term highly active antiretroviral therapy The metabolic effects of lopinavir/ritonavir in HIV-negative men Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: a randomized, placebo-controlled study.Metabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population.Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy Insulin resistance by homeostasis model assessment in HIV-infected patients on highly active antiretroviral therapy: cross-sectional study.Effects of human immunodeficiency virus and metabolic complications on myocardial nutrient metabolism, blood flow, and oxygen consumption: a cross-sectional analysis.Cellular mechanisms of insulin resistance, lipodystrophy and atherosclerosis induced by HIV protease inhibitors.Antiretroviral Drug Levels and Interactions Affect Lipid, Lipoprotein, and Glucose Metabolism in HIV-1 Seronegative Subjects: A Pharmacokinetic-Pharmacodynamic Analysis Risk factors for new-onset diabetes mellitus in patients receiving protease inhibitor therapy An inhibitor of HIV-1 protease modulates constitutive eIF2α dephosphorylation to trigger a specific integrated stress response.Drug-induced endocrine and metabolic disorders.Relationships among HIV infection, metabolic risk factors, and left ventricular structure and function Independent associations of insulin resistance with high whole-body intermuscular and low leg subcutaneous adipose tissue distribution in obese HIV-infected women.Protease inhibitors used in the treatment of HIV+ induce beta-cell apoptosis via the mitochondrial pathway and compromise insulin secretion.Effects of once-daily darunavir/ritonavir versus atazanavir/ritonavir on insulin sensitivity in HIV-infected persons over 48 weeks: results of an exploratory substudy of METABOLIK, a phase 4, randomized trial.HIV protease inhibitors and insulin resistance: lessons from in-vitro, rodent and healthy human volunteer models Pilot study of pioglitazone and exercise training effects on basal myocardial substrate metabolism and left ventricular function in HIV-positive individuals with metabolic complications.Blunted lipolysis and fatty acid oxidation during moderate exercise in HIV-infected subjects taking HAART Diabetes and HIV: current understanding and future perspectives.Sequence-specific alterations of epitope production by HIV protease inhibitors.Insulin resistance and associated factors among HIV-infected patients in sub-Saharan Africa: a cross sectional study from Cameroon.Indinavir uncovers different contributions of GLUT4 and GLUT1 towards glucose uptake in muscle and fat cells and tissues.Prospective, intensive study of metabolic changes associated with 48 weeks of amprenavir-based antiretroviral therapy.Effect of nelfinavir on insulin metabolism, proteasome activity and protein degradation in HepG2 cells.HIV infection and the pancreas: risk factors and potential management guidelines.

P2860

Q22306015-BB091BC1-E136-4A7D-90C6-6567C398AE37 Q28469250-108D3C22-E892-44AA-A5B8-D25F3A811B7E Q28582686-A1030EB8-8D72-4157-961E-C1D52A33FB43 Q28595560-C1A43D91-EEC9-4F3F-BAB2-DF81295DCFDB Q33729269-908E9FDF-9070-43F0-B6D1-7E3A60676458 Q33941936-D64F68C6-5191-4F25-BB0E-794B4A1AF421 Q33983927-CF1BE822-6ABD-4A84-9DC4-0D49A7247A4E Q34092346-5A381D0E-D5C1-4985-A309-D8966256AABE Q34191314-2DF27AE9-3EBD-493C-BDEF-B49BE4D9A2BB Q34299021-30B5E96E-C3CF-4486-A422-12475E824487 Q34455624-B7FA27CD-C785-4F99-BD77-5D1FB3F88525 Q34979921-0DAC9133-8DB0-49D9-BC58-B8CB6186119F Q35141509-0571C041-F830-4BB5-8512-AECB83C838A7 Q35188653-96F069CD-2361-42B3-B92C-52842E14E7CC Q35194049-B6668D95-6B01-4BEE-88CC-84E3BD888920 Q35194394-B4B3CB6C-C9CD-46AC-AEA8-EA408FE892CD Q35195035-7BF2A876-D99D-44AF-9D64-F5EC8515559D Q35206670-E623FCC7-3797-4227-B069-F04304A4967A Q35208120-B365D550-60DA-4C91-89B2-B1B014F6B609 Q35670873-E1C7C28A-7027-48B5-8A43-0B54C68B4370 Q35672526-6EB163E4-BCAF-4F4B-8421-7E7ADAF16FA4 Q36011828-0D7549E3-B9C3-43DA-BAC2-5C600343B2A7 Q36145648-9D637A96-319A-49B1-A710-9C025E7A3F6B Q36171039-BC253DE8-7BE0-434F-BE62-B091FF5B55D2 Q36483172-C6CBE148-2A58-448E-AE5A-DCF9C288BA85 Q36753691-01E705E9-DA19-4775-B1FE-1226A412954B Q37025613-1BE78919-52F3-481D-842E-4A052BD33093 Q37161855-0B6A07B2-077A-4A57-B235-6E2AF787BF6E Q37162243-08DBC6A9-82DD-4B7A-B7FE-262A7F39FB44 Q37250997-9083B6D1-1698-4D4B-B0B8-195EDF2FA22F Q37447923-77DF7B9E-F629-4323-9BD6-92C280CC7B22 Q37602891-BCD908D4-C8FB-44F9-A96F-748878FD9227 Q37604169-9D9E3417-CA68-4B2D-8BE0-DBC0E700BE47 Q38085218-3AD38968-D5BA-4848-8B8E-912516479E7F Q38710071-0DB246DF-0563-43D5-B531-7A74609FDB10 Q40087155-06CC6E13-5B27-4822-844B-6EBE76FEE48E Q42440254-91A08DA5-5BE5-413F-B59E-3BD778CF512F Q44081426-8FBE2E58-8530-4C15-B21A-6EB6B0A12E71 Q44318804-67B4A26B-1644-428E-B45B-9E859EB304CA Q44442725-A47DF349-4F8D-466A-9BEA-6EE46E9D8661

P2860

Insulin resistance in HIV protease inhibitor-associated diabetes.

http://www.wikidata.org/entity/Q35237635

description

1999 nî lūn-bûn

@nan

1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Insulin resistance in HIV protease inhibitor-associated diabetes.

@ast

Insulin resistance in HIV protease inhibitor-associated diabetes.

@en

type

label

Insulin resistance in HIV protease inhibitor-associated diabetes.

@ast

Insulin resistance in HIV protease inhibitor-associated diabetes.

@en

prefLabel

Insulin resistance in HIV protease inhibitor-associated diabetes.

@ast

Insulin resistance in HIV protease inhibitor-associated diabetes.

@en

P1433

Q35237635-3A0445E9-72E8-44FD-BC70-BC42296641E7

P1476

Q35237635-6D0D1F98-919A-44FE-A84C-B974778462B3

P2093

Q35237635-32F1E4C2-DE5B-4516-B1A9-8CC994789696

Q35237635-479C90FD-F061-42BF-8E3A-E40E1FCBDC1C

Q35237635-49B8990A-EED9-4127-B75F-28E2E0D0B0A5

Q35237635-51BB4CAB-B949-460D-9514-74CE744ACFED

Q35237635-5BDDF9F5-D7EC-4E41-ADF9-39EF4C042C7A

Q35237635-5FB91C5C-2A98-45B5-B5BD-980025A145B0

Q35237635-63CE6613-094E-4E0D-99BF-47B683F01120

Q35237635-81C992DD-DE9E-411E-B58B-AA80BF9C1F6B

Q35237635-BFFE11FF-0AAA-493F-89A8-EAF4D43D1C12

P2860

Q35237635-0048FF05-52A5-4EB4-8F34-865595E497DA

Q35237635-10E14627-B58B-4B65-9C6A-5981ED8E0EC0

Q35237635-1B74B295-F7FF-4A05-910E-FA7C6C2A58EE

Q35237635-2025A330-25FB-42F7-B26E-E0897A033A7D

Q35237635-27A6C5E5-AFF9-46C3-AE63-4AE0DDBBE3B0

Q35237635-27A9CAB1-56E0-4D61-BCB1-B4385A7FE0A0

Q35237635-4E9B16D2-B518-4C6C-9A6B-63DA40EBCAC6

Q35237635-4EF539E2-063C-4969-ACEB-92D7A0571F82

Q35237635-59348746-D929-4400-905C-AFA4C073C6AF

Q35237635-6082E2A4-7CA0-4BB3-A76B-5F7FBC49FD04

P304

Q35237635-8353ED63-2432-439D-A190-460C8BE66324

P31

Q35237635-149B9DCD-7B8F-4F4E-B731-51AA4B611E23

P356

Q35237635-269AF4CB-3705-43B5-9AC3-2143230848F4

P407

Q35237635-A8A35121-2ABB-43DA-9D40-5158B4385F81

P433

Q35237635-229227CD-A302-4676-B1BE-3EDC57EC1C33

P478

Q35237635-139661EC-D303-451D-934D-BF327DABEC8C

P577

Q35237635-BB2B883C-07BB-4B95-AE51-75A310150E5A

P5875

Q35237635-F4BBECB3-ED50-44F1-B25E-29AAE1A05139

P698

Q35237635-6C7DF790-6D18-43B4-91E8-AAC37AFEE498

P921

Q35237635-14A35EE1-ECE1-4F95-B7EB-A4DA5A30AB33

P932

Q35237635-D9617D49-09F5-4426-B114-9C7488112313

P356

00126334-199907010-00005

P1433

Journal of Acquired Immune Deficiency Syndromes

P1476

Insulin resistance in HIV protease inhibitor-associated diabetes.

@en

P2093

A Bohrer

http://www.w3.org/2001/XMLSchema#string

C Sigmund

http://www.w3.org/2001/XMLSchema#string

J Turk

http://www.w3.org/2001/XMLSchema#string

K E Yarasheski

http://www.w3.org/2001/XMLSchema#string

P A Halban

http://www.w3.org/2001/XMLSchema#string

P E Cryer

http://www.w3.org/2001/XMLSchema#string

P Tebas

http://www.w3.org/2001/XMLSchema#string

S Dagogo-Jack

http://www.w3.org/2001/XMLSchema#string

W G Powderly

http://www.w3.org/2001/XMLSchema#string

P2860

Brief report: impaired processing of prohormones associated with abnormalities of glucose homeostasis and adrenal function

Pancreatic islets express a Ca2+-independent phospholipase A2 enzyme that contains a repeated structural motif homologous to the integral membrane protein binding domain of ankyrin

Proinsulin processing in the rat insulinoma cell line INS after overexpression of the endoproteases PC2 or PC3 by recombinant adenovirus

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.

The relation of proinsulin, insulin, and proinsulin-to-insulin ratio to insulin sensitivity and acute insulin response in normoglycemic subjects.

Pancreatic beta cells are important targets for the diabetogenic effects of glucocorticoids.

Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance.

Function and inhibition of intracellular calcium-independent phospholipase A2.

Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel.

P304

209-216

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/00126334-199907010-00005

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

1999-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12878792

http://www.w3.org/2001/XMLSchema#string

P698

10421244

http://www.w3.org/2001/XMLSchema#string

P921

P932

3182110

http://www.w3.org/2001/XMLSchema#string